St. Jude Researcher Thanks Donors For New Potential ALS Treatment
Scientists at St. Jude Children's Research Hospital may have discovered enzymes to help treat degenerative neurological diseases while doing unrelated research.
Before explaining how researchers came across this potential treatment, it's important to remember that St. Jude Children's Research Hospital studies more than just cancer. Their team of scientists is also researching catastrophic pediatric illnesses.
In a story shared by WREX, Dr. Mondira Kundu and her team were working on other research when the potential treatment was discovered.
While conducting various tests for study, Dr. Kundu's team discovered that two enzymes, ULK1 and ULK2, can break down cell structures that kill muscle and brain cells.
Dr. Kundu expressed how important St. Jude Partners-In-Hope were in reaching this discovery, according to Memphis NBC affiliate WMC.
Dr. Kundu credits St. Jude’s donors and the fundraising team at ALSAC for making the breakthrough possible.